NCT01376505: Vaccine Therapy in Treating Patients With Metastatic Solid Tumors |
|
|
| Completed | 1 | 65 | US | HER-2 vaccine, Synthetic peptides of HER-2 comprising B cell epitopes with a Promiscuous T cell epitope of Measles Virus., Extension HER-2 vaccine trial at OBD | Robert Wesolowski | Malignant Solid Tumour, Breast Cancer, Malignant Tumor of Colon, GIST, Ovarian Cancer | 11/22 | 11/22 | | |
NCT06414733: Vaccine Therapy in Treating Patients With Metastatic Solid Tumors |
|
|
| Not yet recruiting | 1 | 42 | US | Combination of MVF-HER-2 (597-626) and MVF-HER-2 (266-296) emulsified with ISA 720 | Pravin T.P Kaumaya | Metastatic Breast Cancer, Metastatic Gastrointestinal Carcinoma, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, EGFR Overexpression | 12/26 | 06/27 | | |
